Exrotan Tablet 10/160mg

Adult dose

The recommended dose for this medication is 1 tablet once daily, taken with water regardless of meals. It is advisable to take it at the same time each day (e.g., in the morning). For patients with mild to moderate renal impairment, dose adjustment is not necessary; however, it is not to be administered to patients with severe renal impairment or those on dialysis. For patients with liver impairment, the daily dose of valsartan should not exceed 80mg, and it should not be given to patients with severe liver impairment.

Child dose

The safety and efficacy in children under 18 years of age have not been established, so administration is not recommended.

This medication can cause serious injury or death to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it should be discontinued immediately if pregnancy is confirmed. Patients who have allergies to the main ingredients of this medication or similar ingredients, women who are pregnant or may become pregnant, and nursing mothers should not take this medication. Patients with severely impaired kidney function or severely decreased liver function, those with certain heart conditions, and patients with a history of angioedema should not use this medication, and combination therapy should be avoided in diabetic patients with impaired kidney function. In patients who are deficient in body sodium or fluids, hypotension may occur, so their condition should be assessed before taking the medication, and blood pressure and symptoms should be monitored closely during treatment. Patients with high potassium levels should be cautious when taking this medication alongside drugs that can increase potassium levels and should have their blood potassium levels checked frequently. Patients with renal artery stenosis or those who have received a recent kidney transplant also require careful monitoring of kidney function when using this medication. If angioedema occurs, the medication should be stopped immediately, and re-administration is prohibited. Patients with heart failure or those who have had a myocardial infarction require regular evaluations, including kidney function assessment, and should be cautious as side effects such as pulmonary edema may occur during treatment with this medication. Like other antihypertensives, this medication may cause dizziness or fatigue when driving or operating machinery, so caution is needed. In case of overdose, hypotension and cardiac function abnormalities may occur, so immediate medical treatment should be sought, and cardiovascular function should be actively managed as needed. This medication may interact with certain drugs, so patients should inform their healthcare provider of any other medications they are taking, particularly potassium-sparing diuretics, NSAIDs, and CYP3A4 inhibitors. The safety and efficacy of this medication in children or patients under 18 years of age have not been adequately established and are not recommended. Elderly patients may use a dose similar to that of the general adult population, but care should be taken to consider their physical condition during administration. During treatment with this medication, it is important to regularly check blood pressure, kidney function, electrolyte levels, etc., to detect abnormal signs early and respond appropriately.

Serious side effects

Urticaria, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blisters, skin peeling, pain of oral/ocular mucosa, shortness of breath or difficulty breathing, asthma attack, cough with fever accompanied respiratory abnormalities, yellowing of skin or eyes (jaundice), profound lethargy, sudden and severe headache, thunderclap headache, seizure, confusion, visual disturbances, paralysis, urine

Mild side effects

• Nasopharyngitis
• influenza
• anxiety
• headache
• dizziness
• drowsiness
• orthostatic dizziness
• paresthesia
• lightheadedness
• tinnitus

This medication should be stored in a tightly closed container to avoid exposure to air or moisture. It is important to maintain a storage temperature between 1°C and 30°C.

Appearance

Bright yellow oval film-coated tablet

Package unit

28 tablets/box ((14 tablets/PTP packaging) x 2)